Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2016
Pharma News, 2016
Vitamin D may not be the great solution to health problems
(Edmonton) As Canadians prepare for long summer days in the sun, a new publication is shedding light on the suggested medical benefits of a nutrient that comes with the sun's rays.
ARIAD Initiates Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration Ahead of Plan
CAMBRIDGE, Mass.
India's pharma exports may reach $20 bn by 2020: Study
Delay in regulatory approvals may reduce pharma exports' growth by half.
Congo declares yellow fever epidemic
DR Congo on Monday declared a yellow fever outbreak in the capital Kinshasa, home to more than ten million people, and in two other western provinces.
Biogen targets Cambridge plant, up to 285 jobs at risk
Biogen ($BIIB) will sell or close a manufacturing plant at its headquarters in Cambridge, MA, shedding up to 285 jobs, moving the work there to a more efficient plants in its network.
Bristol's Opdivo-Yervoy melanoma combo wins speedy thumbs up from NICE
It was only yesterday that England’s cost watchdogs shot down a melanoma combination from Roche.
AbbVie North Chicago plant has second fire
An AbbVie ($ABBV) manufacturing facility in North Chicago had a fire in a laboratory this week.
Merck's Keytruda beats out chemotherapy in lung cancer study
Merck's cancer immunotherapy Keytruda beat out standard of care chemotherapy in extending time without worsening symptoms and overall survival among patients with previously untreated non-small ce...
Pfizer begins construction on $200 million biologics plant in MA
Pfizer on Thursday began construction on a new clinical manufacturing facility in Andover, Massachusetts, saying it would invest $200 million in building out the site.
FDA clears Gilotrif as late stage non-small cell lung cancer therapy
The US Food and Drug Administration (FDA) has cleared Boehringer Ingelheim's tyrosine kinase inhibitor Gilotrif (afatinib) as a new medication for patients with late stage (met...
FDA approves vaccine to prevent cholera for travelers
The U.
Can coffee cause cancer? Only if it's very hot, says WHO agency
There is no conclusive evidence that drinking coffee causes cancer, the World Health Organization's cancer agency said on Wednesday in a reverse of its previous warning, but it also said all "...
29
30
31
32
33
34
35
36
37
